Q4 2024 Medifast Inc Earnings Call Transcript
Key Points
- Medifast Inc (MED) reported revenue at the high end of expectations and earnings per share above guidance for Q4 2024.
- The company launched the OPTAVIA ASCEND product line, which has been well-received and aligns with the growing GLP-1 medication market.
- Medifast Inc (MED) achieved $21 million in cost savings in 2024 through its 'Fuel for the Future' initiative, exceeding initial targets.
- The company maintains a strong financial position with no debt and a solid cash balance, providing flexibility for future investments.
- There is a positive trend in coach productivity, with a significant improvement from a 22.2% decline in Q1 2024 to a 5.5% decline in Q4 2024.
- Revenue for Q4 2024 decreased by 37.7% year-over-year, primarily due to a decline in the number of active earning OPTAVIA Coaches and lower coach productivity.
- Customer acquisition continues to face challenges due to the growing adoption of GLP-1 medications.
- The number of active earning OPTAVIA Coaches decreased by 34.1% from the fourth quarter of 2023.
- SG&A expenses as a percentage of revenue increased by 400 basis points, reflecting higher company-led marketing spend.
- The company expects continued pressure on coach numbers and customer acquisition challenges into the first half of 2025.
Greetings, and welcome to the Medifast fourth-quarter 2024 earnings conference call. (Operator Instructions)
As a reminder, this conference is being recorded. It is now my pleasure to introduce Steven Zenker, Vice President, Investor Relations. Please go ahead.
Good afternoon. and welcome to Medifast's fourth-quarter and full-year 2024 earnings conference call. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer.
By now, everyone should have access to the earnings release for the fourth quarter and full year ended December 31, 2024, and that went out this afternoon at approximately 4:05 PM Eastern Time. If you have not received the release, it is available on the Investor Relations portion of Medifast website at www.medifastinc.com. This call is being webcast, and a replay will also be available on the company's website.
Before we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
